Heart of Bureaucratic Darkness
Why won’t the FDA make a decision on a muscular dystrophy drug?
The Wall Street Journal
Aug. 9, 2016 7:10 p.m. ET
Government ineptitude is usually a punch line, but the dark reality is that bureaucratic malfeasance can carry a body count. The Food and Drug Administration is months late deciding whether to approve a drug for muscular dystrophy, and by now…
You can share this discussion in two ways…
Share this link:
Send it with your computer's email program: Email this